WO2002008208A1 - Process for the preparation of optically active thiazolidinone derivatives - Google Patents
Process for the preparation of optically active thiazolidinone derivatives Download PDFInfo
- Publication number
- WO2002008208A1 WO2002008208A1 PCT/JP2001/004953 JP0104953W WO0208208A1 WO 2002008208 A1 WO2002008208 A1 WO 2002008208A1 JP 0104953 W JP0104953 W JP 0104953W WO 0208208 A1 WO0208208 A1 WO 0208208A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- optically active
- preparation
- thiazolidinone derivatives
- active thiazolidinone
- carboxylic acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/14—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2001262746A AU2001262746A1 (en) | 2000-07-26 | 2001-06-12 | Process for the preparation of optically active thiazolidinone derivatives |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000225684A JP2004002206A (en) | 2000-07-26 | 2000-07-26 | Method for producing optically active thiazolidinone derivative |
JP2000-225684 | 2000-07-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2002008208A1 true WO2002008208A1 (en) | 2002-01-31 |
Family
ID=18719420
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2001/004953 WO2002008208A1 (en) | 2000-07-26 | 2001-06-12 | Process for the preparation of optically active thiazolidinone derivatives |
Country Status (3)
Country | Link |
---|---|
JP (1) | JP2004002206A (en) |
AU (1) | AU2001262746A1 (en) |
WO (1) | WO2002008208A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR3120368A1 (en) * | 2021-03-02 | 2022-09-09 | Compagnie Generale Des Etablissements Michelin | Monomers containing a 4-thiazolidinone unit and their polyamide, polyester and polyurethane polycondensates. |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2661827A1 (en) * | 2006-08-23 | 2008-02-28 | Allergan, Inc. | Therapeutic substituted thiazolidinones, oxazolidinones, and related compounds |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0705816A1 (en) * | 1993-06-23 | 1996-04-10 | Chugai Seiyaku Kabushiki Kaisha | Benzene derivative useful for ischemic diseases |
EP0845454A1 (en) * | 1996-12-02 | 1998-06-03 | Ajinomoto Co., Inc. | Method for the production of optically active cyclopropane derivatives |
JPH1180149A (en) * | 1997-09-11 | 1999-03-26 | Kuraray Co Ltd | Optical resolution of (+,-)-chromancarboxylic acid |
JP2000119228A (en) * | 1998-10-09 | 2000-04-25 | Sumitomo Chem Co Ltd | Production of optically active benzylamine |
-
2000
- 2000-07-26 JP JP2000225684A patent/JP2004002206A/en active Pending
-
2001
- 2001-06-12 WO PCT/JP2001/004953 patent/WO2002008208A1/en active Application Filing
- 2001-06-12 AU AU2001262746A patent/AU2001262746A1/en not_active Abandoned
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0705816A1 (en) * | 1993-06-23 | 1996-04-10 | Chugai Seiyaku Kabushiki Kaisha | Benzene derivative useful for ischemic diseases |
EP0845454A1 (en) * | 1996-12-02 | 1998-06-03 | Ajinomoto Co., Inc. | Method for the production of optically active cyclopropane derivatives |
JPH1180149A (en) * | 1997-09-11 | 1999-03-26 | Kuraray Co Ltd | Optical resolution of (+,-)-chromancarboxylic acid |
JP2000119228A (en) * | 1998-10-09 | 2000-04-25 | Sumitomo Chem Co Ltd | Production of optically active benzylamine |
Non-Patent Citations (4)
Title |
---|
KATO T. ET AL.: "Novel calcium antoganists with both calcium overload inhibition and antioxidant activity. 2. Structure-activity relationships of thiazolidinone derivatives", J. MED. CHEM., vol. 42, 1999, pages 3134 - 3146, XP002942300 * |
KATO T. ET AL.: "Practical synthesis of novel cardioprotective drug, CP-060S", ORG. PROC. RES. AND DEV., vol. 5, no. 2, 2001, pages 122 - 126, XP002942401 * |
MORRISON R.T. ET AL., TRANSLATION: K. NAKANISHI ET AL.: "Morrison boyd yuuki kagaku", 1995, TOKYO KAGAKU DOJIN, XP002942299 * |
TIERZE L.F. ET AL., TRANSLATION: SEICHI KOUNO ET AL.: "Seimitsu yuuki kagaku 'Jikken manual'", 1995, NANKOUDOU, XP002942298 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR3120368A1 (en) * | 2021-03-02 | 2022-09-09 | Compagnie Generale Des Etablissements Michelin | Monomers containing a 4-thiazolidinone unit and their polyamide, polyester and polyurethane polycondensates. |
Also Published As
Publication number | Publication date |
---|---|
AU2001262746A1 (en) | 2002-02-05 |
JP2004002206A (en) | 2004-01-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BG106786A (en) | Process for the preparation of amorphous atorvastatin | |
DK0520406T3 (en) | Diastereomeric salt of optically active quinoline mevalonic acid | |
EP1457487A4 (en) | Process for production of optically active cis-piperidine derivatives | |
CA2432064A1 (en) | Novel process for the synthesis of 5-(4-fluorophenyl)-1-[2-((2r,4r)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1h-pyrrole-3-carboxylic acid phenylamide | |
DK0845464T3 (en) | S-type 2-substituted hydroxy-2-indolidinyl butyric acid ester compounds as intermediates for camptothecin derivatives | |
CA2065008A1 (en) | Light Activated Acyl-Enzymes | |
CA2272716A1 (en) | Resolution of ritalinic acid salt | |
AU1289600A (en) | Process for racemization | |
WO2002008208A1 (en) | Process for the preparation of optically active thiazolidinone derivatives | |
NO20033917D0 (en) | Process for the preparation of 2-azetidinone derivative | |
AU6117598A (en) | Compounds | |
AU7002096A (en) | Production of amide derivatives and intermediates therefor | |
PL326267A1 (en) | Method of obtaining (1s,4r)- or (1r,4s)-4(2-amino-6-chloro-9h-purinyl-9)-cyclopentene-1-methanol | |
EP1571138A4 (en) | Processes for producing (4e)-5-chloro-2-isopropyl-4-pentenoic ester and optically active isomer thereof | |
MXPA03011647A (en) | Resolution process for (r)-(-)-2-hydroxy-2-(2-chlorophenyl) acetic acid. | |
DK0464488T3 (en) | Optically active N-alpha-fluoroacryloylamino acid derivatives, their preparation, their optically active polymers prepared and their use for cleavage of racemates | |
WO2002059089A3 (en) | Process for the preparation of heterocyclic indene analogs | |
MXPA01011104A (en) | Process for synthesizing n-(mercaptoacyl) amino acid derivatives from alpha-substituted acrylic acids. | |
CA2320756A1 (en) | Process for the production of optically enriched (r)- or (s)-albuterol | |
Senanayake et al. | Rabbit liver esterase-mediated enantioselective synthesis of 2-arylpropanoic acids | |
IL108829A0 (en) | Enzymatic resolution of alkyl 2-piperidinecarboxylates and use of the compounds obtained as synthesis intermediates | |
EP1340743A4 (en) | Optically active amine derivative and method of synthesis | |
DE69809888T2 (en) | Process for the preparation of alpha-aminoketones | |
EP1693364A4 (en) | Intermediates for the production of optically active cyclopropylamine derivatives and process for the production of the intermediates | |
BR0013025A (en) | Process for preparing acids via alpha-chloroeppoxy esters |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |